Search for: "MG v. United States of America"
Results 1 - 10
of 10
Sorted by Relevance
|
Sort by Date
3 Mar 2019, 12:38 pm
The license agreement granted MGI the right to distribute, promote, market, and sell the 0.25 mg and 0.75 mg doses of palonosetron in the United States. [read post]
11 Feb 2019, 12:15 pm
The Supreme Court of the United States has affirmed the Federal Circuits’ Decision for the Helsinn Healthcare v. [read post]
6 Nov 2019, 2:13 am
Co. v. [read post]
30 Nov 2017, 5:47 pm
"from FTC v. [read post]
2 Feb 2018, 1:31 pm
The new law no longer requires an invalidating sale to be in the United States – now it can be anywhere. [read post]
31 Jan 2019, 1:00 am
In Pfaff v. [read post]
30 Oct 2013, 10:57 am
of America v. [read post]
17 Mar 2020, 1:32 pm
One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) has been recalled by Teva Pharmaceuticals due to the presence of particulate matter. [read post]
30 Jun 2015, 2:57 am
Perhaps worse, this standard is stated as being the standard for the Lanham Act in a state law consumer protection case, with citation of but no apparent comprehension of the difference between literal falsity and literal truth that is nonetheless misleading. [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
